Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3.

Karyo R, Eskira Y, Pinhasov A, Belmaker R, Agam G, Eldar-Finkelman H.

Mol Cell Neurosci. 2010 Dec;45(4):449-55. doi: 10.1016/j.mcn.2010.08.004. Epub 2010 Aug 12.

PMID:
20708687
[PubMed - indexed for MEDLINE]
2.

Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.

Kirshenboim N, Plotkin B, Shlomo SB, Kaidanovich-Beilin O, Eldar-Finkelman H.

J Mol Neurosci. 2004;24(2):237-45.

PMID:
15456937
[PubMed - indexed for MEDLINE]
3.

Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.

Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leão P, Almeida OF, Sousa N.

Neuroscience. 2008 Mar 27;152(3):656-69. doi: 10.1016/j.neuroscience.2007.12.026. Epub 2007 Dec 23.

PMID:
18291594
[PubMed - indexed for MEDLINE]
4.

Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury.

Shapira M, Licht A, Milman A, Pick CG, Shohami E, Eldar-Finkelman H.

Mol Cell Neurosci. 2007 Apr;34(4):571-7. Epub 2006 Dec 28.

PMID:
17289399
[PubMed - indexed for MEDLINE]
5.

Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.

Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS.

J Biol Chem. 2003 Aug 29;278(35):33067-77. Epub 2003 Jun 7.

PMID:
12796505
[PubMed - indexed for MEDLINE]
Free Article
6.

Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3β phosphorylation in the central clock.

Kinoshita C, Miyazaki K, Ishida N.

Neuroreport. 2012 Jan 25;23(2):98-102. doi: 10.1097/WNR.0b013e32834e7ec2.

PMID:
22158133
[PubMed - indexed for MEDLINE]
7.
8.

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

Chen G, Huang LD, Jiang YM, Manji HK.

J Neurochem. 1999 Mar;72(3):1327-30.

PMID:
10037507
[PubMed - indexed for MEDLINE]
9.

Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.

Wada A.

J Pharmacol Sci. 2009 May;110(1):14-28. Epub 2009 May 8. Review.

PMID:
19423950
[PubMed - indexed for MEDLINE]
Free Article
10.

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Gould TD, Manji HK.

Neuropsychopharmacology. 2005 Jul;30(7):1223-37. Review.

PMID:
15827567
[PubMed - indexed for MEDLINE]
Free Article
11.

Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling.

Liberman Z, Eldar-Finkelman H.

J Biol Chem. 2005 Feb 11;280(6):4422-8. Epub 2004 Nov 30.

PMID:
15574412
[PubMed - indexed for MEDLINE]
Free Article
12.

Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.

Jin N, Kovács AD, Sui Z, Dewhurst S, Maggirwar SB.

Neuropharmacology. 2005 Mar;48(4):576-83. Epub 2005 Jan 25.

PMID:
15755485
[PubMed - indexed for MEDLINE]
13.

Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.

Leng Y, Liang MH, Ren M, Marinova Z, Leeds P, Chuang DM.

J Neurosci. 2008 Mar 5;28(10):2576-88. doi: 10.1523/JNEUROSCI.5467-07.2008.

PMID:
18322101
[PubMed - indexed for MEDLINE]
Free Article
14.

A pharmacoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death.

Boyce M, Py BF, Ryazanov AG, Minden JS, Long K, Ma D, Yuan J.

Cell Death Differ. 2008 Mar;15(3):589-99. doi: 10.1038/sj.cdd.4402296. Epub 2008 Jan 11.

PMID:
18188169
[PubMed - indexed for MEDLINE]
Free Article
15.

A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.

Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, Tragon T, Hunsberger JG, Machado-Vieira R, Drevets W, Wang YT, Manji HK.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11573-8. doi: 10.1073/pnas.0913138107. Epub 2010 Jun 7.

PMID:
20534517
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity.

Medunjanin S, Hermani A, De Servi B, Grisouard J, Rincke G, Mayer D.

J Biol Chem. 2005 Sep 23;280(38):33006-14. Epub 2005 Aug 1.

PMID:
16076840
[PubMed - indexed for MEDLINE]
Free Article
17.

Phosphorylation of eukaryotic elongation factor 2 in differentiating and proliferating HL-60 cells.

Nilsson A, Nygård O.

Biochim Biophys Acta. 1995 Sep 21;1268(3):263-8.

PMID:
7548224
[PubMed - indexed for MEDLINE]
18.

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H.

Biol Psychiatry. 2004 Apr 15;55(8):781-4.

PMID:
15050857
[PubMed - indexed for MEDLINE]
19.

Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.

Yeste-Velasco M, Folch J, Trullàs R, Abad MA, Enguita M, Pallàs M, Camins A.

Neuropharmacology. 2007 Aug;53(2):295-307. Epub 2007 May 26.

PMID:
17612578
[PubMed - indexed for MEDLINE]
20.

Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium.

Lucas FR, Goold RG, Gordon-Weeks PR, Salinas PC.

J Cell Sci. 1998 May;111 ( Pt 10):1351-61.

PMID:
9570753
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk